Waystar Holding Corp. (WAY)
NASDAQ: WAY · Real-Time Price · USD
25.08
+0.54 (2.20%)
At close: Aug 13, 2026, 4:00 PM EDT
25.05
-0.03 (-0.12%)
Pre-market: Aug 14, 2026, 7:22 AM EDT
Waystar Holding Revenue
Waystar Holding had revenue of $319.67M in the quarter ending June 30, 2026, with 18.11% growth. This brings the company's revenue in the last twelve months to $1.21B, up 19.23% year-over-year. In the year 2025, Waystar Holding had annual revenue of $1.10B with 16.50% growth.
Revenue (ttm)
$1.21B
Revenue Growth
+19.23%
P/S Ratio
3.99
Revenue / Employee
$709,257
Employees
1,700
Market Cap
4.81B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.10B | 155.73M | 16.50% |
| Dec 31, 2024 | 943.55M | 152.54M | 19.28% |
| Dec 31, 2023 | 791.01M | 86.14M | 12.22% |
| Dec 31, 2022 | 704.87M | 126.31M | 21.83% |
| Dec 31, 2021 | 578.57M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BrightSpring Health Services | 14.37B |
| Privia Health Group | 2.36B |
| Tempus AI | 1.43B |
| HealthEquity | 1.34B |
| Omnicell | 1.25B |
| Hinge Health | 720.06M |
| Doximity | 655.57M |
| 10x Genomics | 616.91M |
WAY News
- 7 days ago - Waystar price target raised to $27 from $25 at Barclays - TheFly
- 13 days ago - Waystar price target raised to $39 from $36 at Deutsche Bank - TheFly
- 14 days ago - Waystar price target lowered to $32 from $34 at JPMorgan - TheFly
- 14 days ago - Waystar price target lowered to $33 from $37 at UBS - TheFly
- 15 days ago - Waystar price target lowered to $33 from $36 at Wells Fargo - TheFly
- 15 days ago - Waystar names Alpana Wegner as CFO - TheFly
- 15 days ago - Waystar Holding Earnings Call Transcript: Q2 2026 - Transcripts
- 15 days ago - Waystar Holding Earnings release: Q2 2026 - Filings